[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Article
January 17, 1948

Annual Reprint of the Reports of the Council on Pharmacy and Chemistry of the American Medical Association for 1946, with the Comments that Have Appeared in the Journal

JAMA. 1948;136(3):213. doi:10.1001/jama.1948.02890200067028

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

This volume presents not only reports on the medicinal articles which the Council has found unacceptable for inclusion in New and Nonofficial Remedies during the past year but also status reports on therapeutic advances and procedures and on promising drugs.

Widespread attention was attracted by publication in The Journal of the report of Dr. S. M. Feinberg, "Histamine and Antihistaminic Agents," sponsored by the Council, which appears in this volume. Since it was first published the Council has accepted for inclusion in New and Nonofficial Remedies the two new agents evaluated in the article, diphenhydramine hydrochloride and tripelennamine hydrochloride ("benadryl hydrochloride" and "pyribenzamine hydrochloride," respectively).

During the past year the Council has reported on three unacceptable preparations: Cabasil, an unscientific mixture, the exploitation of which for use in a multitude of disease conditions is aptly expressed in the title, "Quackery Unlimited"; the pseudoscientific ethylene disulphonate (Allergosil brand), a preparation of

×